Cristina Müller

Title: Cristina Müller: Innovator in Radiopeptide Research

Introduction

Cristina Müller is a prominent inventor based in Nussbaumen, Switzerland. She has made significant contributions to the field of radiopharmaceuticals, particularly in the development of radiopeptides for cancer treatment. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.

Latest Patents

One of her latest patents involves the creation of a radiopeptide that comprises a radionuclide, specifically terbium-161, along with a chelator coordinating this radionuclide and a peptide or peptide analogue that acts as a somatostatin receptor antagonist. This radiopeptide is designed for use in the treatment of tumor diseases. Another notable patent focuses on PSMA-binding agents, which are novel compounds useful as radiopharmaceuticals and imaging agents for cancer treatment.

Career Highlights

Cristina has worked with esteemed organizations such as the Paul Scherrer Institut and ITM Isotope Technologies Munich SE. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Throughout her career, Cristina has collaborated with notable professionals in her field, including Roger Schibli and Martina Benesova. These partnerships have enhanced her research and expanded the impact of her inventions.

Conclusion

Cristina Müller is a trailblazer in the field of radiopeptide research, with her innovative patents contributing to advancements in cancer treatment. Her work exemplifies the importance of collaboration and innovation in the scientific community.